Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Depreciation & Amortization (IS)EBIAT Gross Profit Leases Long-Term Debt Issuances Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

iSpecimen (ISPC) Shares Issued (2021 - 2025)

iSpecimen has reported Shares Issued over the past 5 years, most recently at $2.2 million for Q4 2025.

For Q4 2025, Shares Issued rose 305.26% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.9 million, up 629.02%, while the annual FY2025 figure was $4.0 million, 903.8% up from the prior year.
Shares Issued for Q4 2025 was $2.2 million at iSpecimen, up from $1.8 million in the prior quarter.
Over five years, Shares Issued peaked at $2.2 million in Q4 2025 and troughed at -$15.5 million in Q3 2021.
A 5-year average of -$1.0 million and a median of $3153.0 in 2023 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: fell 10.02% in 2023 and later soared 42904.35% in 2024.
Year by year, Shares Issued stood at -$2.5 million in 2021, then soared by 100.01% to $254.0 in 2022, then surged by 1141.34% to $3153.0 in 2023, then tumbled by 34859.66% to -$1.1 million in 2024, then surged by 305.26% to $2.2 million in 2025.
Business Quant data shows Shares Issued for ISPC at $2.2 million in Q4 2025, $1.8 million in Q3 2025, and -$1.1 million in Q4 2024.